STI571 administered to chronic myeloid leukemia (CML) patients inhibits cell proliferation, induces apoptosis and initially causes partial inhibition of BCR/ABL autophosphorylation
2000-01-01 Gambacorti-Passerini, C; Verga, M; Rossi, F; Tornaghi, L; Bungaro, S; Ruchatz, H; Rossi, F; Pioltelli, P; Pogliani, E; Garattini, E; Capdeville, R; D'Incalci, M; Corneo, G
The Neuroprotective Effect of Erythropoietin in Docetaxel-Induced Peripheral Neuropathy Causes No Reduction of Antitumor Activity in 13762 Adenocarcinoma-Bearing Rats
2010-01-01 Cervellini, I; Bello, E; Frapolli, R; Porretta-Serapiglia, C; Oggioni, N; Canta, A; Lombardi, R; Camozzi, F; Roglio, I; Melcangi, Rc; D'Incalci, M; Lauria, G; Ghezzi, P; Cavaletti, G; Bianchi, R
Characterization of a protein recognizing minor groove binders-damaged DNA
1996-01-01 Colella, G; Bonfanti, M; D'Incalci, M; Broggini, M
Trabectedin mechanism of action: what's new?
2013-01-01 D'Incalci, M
High-performance liquid chromatography tandem mass spectrometry procedure with automated solid phase extraction sample preparation for the quantitative determination of paclitaxel (Taxol (R)) in human plasma
1998-01-01 Sottani, C; Minoia, C; D'Incalci, M; Paganini, M; Zucchetti, M
Mode of action of Ecteinascidin 743, a natural marine compound with antitumoral activity
1998-01-01 Erba, E; Bergamaschi, D; Ronzoni, S; Faretta, M; Bassano, L; Cappella, P; Valoti, G; Giavazzi, R; Jimeno, J; Faircloth, G; D'Incalci, M
Marine (MA) depsipeptides (DEP) with activity (A) against solid tumours (ST) models
1995-01-01 Faircloth, G; Perez, J; Puentes, Jlf; Scheuer, P; Avila, J; Garciarocha, M; Erba, E; D'Incalci, M; Canedo, A; Gravalos, Dg; Dequesada, Tg; Jimeno, J
Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine
2002-01-01 Erba, E; Bassano, L; Di Liberti, G; Muradore, I; Chiorino, G; Ubezio, P; Vignati, S; Codegoni, A; Desiderio, Ma; Faircloth, G; Jimeno, J; D'Incalci, M
L-asparagine depletion in plasma and cerebro-spinal fluid of children with acute lymphoblastic leukemia during subsequent exposures to Erwinia L-asparaginase
1996-01-01 Gentili, D; Conter, V; Rizzari, C; Tschuemperlin, B; Zucchetti, M; Orlandoni, D; D'Incalci, M; Masera, G
COMPARISON OF CELL-CYCLE PHASE PERTURBATIONS INDUCED BY THE DNA-MINOR-GROOVE ALKYLATOR TALLIMUSTINE AND BY MELPHALAN IN THE SW626 CELL-LINE
1995-01-01 Erba, E; Mascellani, E; Pifferi, A; D'Incalci, M
Pharmacokinetics and pharmacodynamics of the novel proteasome inhibitor CEP-18770 during a phase I trial in patients with solid tumor, non-Hodgkin lymphoma or multiple myeloma
2010-01-01 Sala, F; Marangon, E; Brunelli, D; Sessa, C; Dall'O, E; Cereda, R; Livi, V; D'Incalci, M; Zucchetti, M
Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus
2016-01-01 Harlow, Ml; Maloney, N; Roland, J; Navarro, Mjg; Easton, M; Kitchen-Goosen, Sm; Boguslawski, Ea; Madaj, Zb; Johnson, Bk; Bowman, Mj; D'Incalci, M; Winn, Me; Turner, L; Hostetter, G; Galmarini, Cm; Aviles, Pm; Grohar, Pj
E-3810 antitumor activity in human xenografts expressing different levels of FGF receptor 1
2011-01-01 Colella, G; Damia, G; D'Incalci, M; Cereda, R; Peitz, I; Kelter, G; Cavalletti, E; Spinelli, S; Camboni, G
On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts
2013-01-01 Iachettini, S; Stevens, Mfg; Frigerio, M; Hummersone, Mg; Hutchinson, I; Garner, Tp; Searle, Ms; Wilson, Dw; Munde, M; Nanjunda, R; D'Angelo, C; Zizza, P; Rizzo, A; Cingolani, C; De Cicco, F; Porru, M; D'Incalci, M; Leonetti, C; Biroccio, A; Salvati, E
Mode of action of thiocoraline, a natural marine compound with anti-tumour activity
1999-01-01 Erba, E; Bergamaschi, D; Ronzoni, S; Faretta, M; Taverna, S; Bonfanti, M; Catapano, Cv; Faircloth, G; Jimeno, J; D'Incalci, M
Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer
2012-01-01 Mosig, Ra; Lin, L; Senturk, E; Shah, H; Huang, F; Schlosshauer, P; Cohen, S; Fruscio, R; Marchini, S; D'Incalci, M; Sachidanandam, R; Dottino, P; Martignetti, Ja
DIFFERENTIAL EXPRESSION OF C-FOS PROTOONCOGENE IN 2 SUBCLONES DERIVED FROM A HUMAN OVARIAN-CANCER CELL-LINE
1995-01-01 Cattabeni, M; D'Incalci, M; Broggini, M
COMPARISON OF THE MODE OF ACTION AND ANTITUMOR ACTIVITY OF TRABECTEDIN AND ITS TWO DERIVATES, ZALYPSIS (R) AND PM01183
2011-01-01 Romano, M; Frapolli, R; Uboldi, S; Bello, E; Sala, F; Zucchetti, M; Aviles, P; Galmarini, C; D'Incalci, M; Erba, E
Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer
2009-01-01 Sessa, C; Perotti, A; Noberasco, C; De Braud, F; Gallerani, E; Cresta, S; Zucchetti, M; Vigano, L; Locatelli, A; Jimeno, J; Feilchenfeldt, Jw; D'Incalci, M; Capri, G; Ielmini, N; Gianni, L
Thiocoraline, a novel DNA polymerase inhibitor with a higher cytotoxic potency against cancer cells with mutated or inactivated p53
1998-01-01 Erba, E; Bergamaschi, D; Ronzoni, S; Faretta, M; Bassano, L; Vikhanskaya, F; Jimeno, J; Faircloth, G; Catapano, Cv; D'Incalci, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| STI571 administered to chronic myeloid leukemia (CML) patients inhibits cell proliferation, induces apoptosis and initially causes partial inhibition of BCR/ABL autophosphorylation | 1-gen-2000 | Gambacorti-Passerini, C; Verga, M; Rossi, F; Tornaghi, L; Bungaro, S; Ruchatz, H; Rossi, F; Pioltelli, P; Pogliani, E; Garattini, E; Capdeville, R; D'Incalci, M; Corneo, G | |
| The Neuroprotective Effect of Erythropoietin in Docetaxel-Induced Peripheral Neuropathy Causes No Reduction of Antitumor Activity in 13762 Adenocarcinoma-Bearing Rats | 1-gen-2010 | Cervellini, I; Bello, E; Frapolli, R; Porretta-Serapiglia, C; Oggioni, N; Canta, A; Lombardi, R; Camozzi, F; Roglio, I; Melcangi, Rc; D'Incalci, M; Lauria, G; Ghezzi, P; Cavaletti, G; Bianchi, R | |
| Characterization of a protein recognizing minor groove binders-damaged DNA | 1-gen-1996 | Colella, G; Bonfanti, M; D'Incalci, M; Broggini, M | |
| Trabectedin mechanism of action: what's new? | 1-gen-2013 | D'Incalci, M | |
| High-performance liquid chromatography tandem mass spectrometry procedure with automated solid phase extraction sample preparation for the quantitative determination of paclitaxel (Taxol (R)) in human plasma | 1-gen-1998 | Sottani, C; Minoia, C; D'Incalci, M; Paganini, M; Zucchetti, M | |
| Mode of action of Ecteinascidin 743, a natural marine compound with antitumoral activity | 1-gen-1998 | Erba, E; Bergamaschi, D; Ronzoni, S; Faretta, M; Bassano, L; Cappella, P; Valoti, G; Giavazzi, R; Jimeno, J; Faircloth, G; D'Incalci, M | |
| Marine (MA) depsipeptides (DEP) with activity (A) against solid tumours (ST) models | 1-gen-1995 | Faircloth, G; Perez, J; Puentes, Jlf; Scheuer, P; Avila, J; Garciarocha, M; Erba, E; D'Incalci, M; Canedo, A; Gravalos, Dg; Dequesada, Tg; Jimeno, J | |
| Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine | 1-gen-2002 | Erba, E; Bassano, L; Di Liberti, G; Muradore, I; Chiorino, G; Ubezio, P; Vignati, S; Codegoni, A; Desiderio, Ma; Faircloth, G; Jimeno, J; D'Incalci, M | |
| L-asparagine depletion in plasma and cerebro-spinal fluid of children with acute lymphoblastic leukemia during subsequent exposures to Erwinia L-asparaginase | 1-gen-1996 | Gentili, D; Conter, V; Rizzari, C; Tschuemperlin, B; Zucchetti, M; Orlandoni, D; D'Incalci, M; Masera, G | |
| COMPARISON OF CELL-CYCLE PHASE PERTURBATIONS INDUCED BY THE DNA-MINOR-GROOVE ALKYLATOR TALLIMUSTINE AND BY MELPHALAN IN THE SW626 CELL-LINE | 1-gen-1995 | Erba, E; Mascellani, E; Pifferi, A; D'Incalci, M | |
| Pharmacokinetics and pharmacodynamics of the novel proteasome inhibitor CEP-18770 during a phase I trial in patients with solid tumor, non-Hodgkin lymphoma or multiple myeloma | 1-gen-2010 | Sala, F; Marangon, E; Brunelli, D; Sessa, C; Dall'O, E; Cereda, R; Livi, V; D'Incalci, M; Zucchetti, M | |
| Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus | 1-gen-2016 | Harlow, Ml; Maloney, N; Roland, J; Navarro, Mjg; Easton, M; Kitchen-Goosen, Sm; Boguslawski, Ea; Madaj, Zb; Johnson, Bk; Bowman, Mj; D'Incalci, M; Winn, Me; Turner, L; Hostetter, G; Galmarini, Cm; Aviles, Pm; Grohar, Pj | |
| E-3810 antitumor activity in human xenografts expressing different levels of FGF receptor 1 | 1-gen-2011 | Colella, G; Damia, G; D'Incalci, M; Cereda, R; Peitz, I; Kelter, G; Cavalletti, E; Spinelli, S; Camboni, G | |
| On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts | 1-gen-2013 | Iachettini, S; Stevens, Mfg; Frigerio, M; Hummersone, Mg; Hutchinson, I; Garner, Tp; Searle, Ms; Wilson, Dw; Munde, M; Nanjunda, R; D'Angelo, C; Zizza, P; Rizzo, A; Cingolani, C; De Cicco, F; Porru, M; D'Incalci, M; Leonetti, C; Biroccio, A; Salvati, E | |
| Mode of action of thiocoraline, a natural marine compound with anti-tumour activity | 1-gen-1999 | Erba, E; Bergamaschi, D; Ronzoni, S; Faretta, M; Taverna, S; Bonfanti, M; Catapano, Cv; Faircloth, G; Jimeno, J; D'Incalci, M | |
| Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer | 1-gen-2012 | Mosig, Ra; Lin, L; Senturk, E; Shah, H; Huang, F; Schlosshauer, P; Cohen, S; Fruscio, R; Marchini, S; D'Incalci, M; Sachidanandam, R; Dottino, P; Martignetti, Ja | |
| DIFFERENTIAL EXPRESSION OF C-FOS PROTOONCOGENE IN 2 SUBCLONES DERIVED FROM A HUMAN OVARIAN-CANCER CELL-LINE | 1-gen-1995 | Cattabeni, M; D'Incalci, M; Broggini, M | |
| COMPARISON OF THE MODE OF ACTION AND ANTITUMOR ACTIVITY OF TRABECTEDIN AND ITS TWO DERIVATES, ZALYPSIS (R) AND PM01183 | 1-gen-2011 | Romano, M; Frapolli, R; Uboldi, S; Bello, E; Sala, F; Zucchetti, M; Aviles, P; Galmarini, C; D'Incalci, M; Erba, E | |
| Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer | 1-gen-2009 | Sessa, C; Perotti, A; Noberasco, C; De Braud, F; Gallerani, E; Cresta, S; Zucchetti, M; Vigano, L; Locatelli, A; Jimeno, J; Feilchenfeldt, Jw; D'Incalci, M; Capri, G; Ielmini, N; Gianni, L | |
| Thiocoraline, a novel DNA polymerase inhibitor with a higher cytotoxic potency against cancer cells with mutated or inactivated p53 | 1-gen-1998 | Erba, E; Bergamaschi, D; Ronzoni, S; Faretta, M; Bassano, L; Vikhanskaya, F; Jimeno, J; Faircloth, G; Catapano, Cv; D'Incalci, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891